Gangliosides, Ab1 and Ab2 antibodies. III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner

Molecular Immunology

Volumn 44, Issue 11, 2007, Pages 2915-2922

  López Requena, Alejandro ^a,b   Bestagno, Marco ^b   Mateo de Acosta, Cristina ^a   Cesco Gaspere, Michela ^b   Vázquez, Ana María ^a   Pérez, Rolando ^a   Burrone, Oscar R ^b  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Anti idiotypic antibodies; Idiotype; Immunogenicity; rAAV; SIP

Indexed keywords

GANGLIOSIDE AB1 ANTIBODY; GANGLIOSIDE AB2 ANTIBODY; GANGLIOSIDE ANTIBODY; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P3; PROTEIN; SMALL IMMUNE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DIMERIZATION; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; GENE GUN; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOLISTICS; DNA; FEMALE; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN IDIOTYPES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES;

ADENO-ASSOCIATED VIRUS; MURINAE; MUS;

EID: 33947110857     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.010     Document Type: Article

References (45)

1. Alfonso M., Díaz A., Hernández A.M., Pérez A., Rodríguez E., Bitton R., Pérez R., and Vázquez A.M. An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients. J. Immunol. 168 (2002) 2523-2529
2. Alfonso M., Vázquez A.M., Carr A., Haerslev T., Fernández L.E., Lanio M.E., Alvarez C., Zeuthen J., and Pérez R. T-cell independent B-cell response to self monosialogangliosides: primary response monoclonal antibodies. Hybridoma 14 (1995) 209-216
3. Ashkar A.A., and Rosenthal K.L. Toll-like receptor 9 CpG DNA and innate immunity. Curr. Mol. Med. 2 (2002) 545-556
4. Benvenuti F., and Burrone O.R. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants. Gene Ther. 8 (2001) 1555-1561
5. Bessis N., GarciaCozar F.J., and Boissier M.C. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther. Suppl. 1 (2004) S10-S17
6. Bestagno M., Vangelista L., Mandiola P.A., Mukherjee S., Sepúlveda J., and Burrone O.R. Membrane immunoglobulins are stabilized by interchain disulfide bonds occurring within the extracellular membrane-proximal domain. Biochemistry 40 (2001) 10686-10692
7. Bhattacharya-Chatterjee M., Chatterjee S.K., and Foon K.A. Anti-idiotype vaccine against cancer. Immunol. Lett. 74 (2000) 51-58
8. Cao W., Tykodi S.S., Esser M.T., Braciale V.L., and Braciale T.J. Partial activation of CD8+ T cells by a self-derived peptide. Nature 378 (1995) 295-298
9. Carr A., Mullet A., Mazorra Z., Vázquez A.M., Alfonso M., Mesa C., Rengifo E., Pérez R., and Fernández L.E. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 19 (2000) 241-247
10. Cesco-Gaspere M., Benvenuti F., and Burrone O.R. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies. Cancer Immunol. Immunother. 54 (2005) 351-358
11. Díaz A., Alfonso M., Alonso R., Sáurez G., Troche M., Catalá M., Díaz R.M., Pérez R., and Vázquez A.M. Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clin. Immunol. 107 (2003) 80-89
12. Eyerman M.C., and Wysocki L. T cell recognition of somatically-generated Ab diversity. J. Immunol. 152 (1994) 1569-1577
13. Eyerman M.C., Zhang X., and Wysocki L.J. T cell recognition and tolerance of antibody diversity. J. Immunol. 157 (1996) 1037-1046
14. Fernández L.E., Alonso D.F., Gómez D.E., and Vázquez A.M. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer. Exp. Rev. Vaccines 2 (2003) 89-95
15. Grimm D., and Kleinschmidt J.A. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum. Gene Ther. 10 (1999) 2445-2450
16. Guthmann M.D., Castro M., Cinat G., Venier C., Koliren L., Bitton R.J., Vázquez A.M., and Fainboim L. Cellular and humoral anti-ganglioside response after prolonged anti-idiotypic immunotherapy in breast cancer patients. J. Immunother. 29 (2006) 215-223
17. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
18. Hernández A.M., Rodríguez M., López-Requena A., Beausoleil I., Pérez R., and Vázquez A.M. Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: a self versus non-self matter. Immunobiology 210 (2005) 11-21
19. Klinman D.M. Use of CpG oligodeoxynucleotides as immunoprotective agents. Exp. Opin. Biol. Ther. 4 (2004) 937-946
20. Koda T., Aosasa M., Asaoka H., Nakaba H., and Matsuda H. Application of tyramide signal amplification for detection of N-glycolylneuraminic acid in human hepatocellular carcinoma. Int. J. Clin. Oncol. 8 (2003) 317-321
21. Li E., Pedraza A., Bestagno M., Mancardi S., Sanchez R., and Burrone O. Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng. 10 (1997) 731-736
22. Lopez-Requena A., Mateo de Acosta C., Bestagno M., Vázquez A.M., Pérez R., and Burrone O.R. Gangliosides, Ab1 and Ab2 Antibodies IV. Dominance of VH domain in the induction of anti-idiotypic antibodies by gene gun immunization. Mol Immunol. 44 (2007) 3070-3075
23. Lopez-Requena A., Mateo de Acosta C., Moreno E., Gonzalez M., Puchades Y., Talavera A., Vispo N.S., Vazquez A.M., and Perez R. Gangliosides Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype system. Mol. Immunol. 44 (2007) 423-433
24. Lopez-Requena A., Mateo de Acosta C., Perez A., Valle A., Lombardero J., Sosa K., Perez R., and Vazquez A.M. Chimeric anti-N-glycolyl-ganglioside and its anti-idiotypic MAbs: immunodominance of their variable regions. Hybrid Hybridomics 22 (2003) 235-243
25. Lopez-Requena A., Rodriguez M., Mateo de Acosta C., Moreno E., Puchades Y., Gonzalez M., Talavera A., Valle A., Hernandez T., Vazquez A.M., and Perez R. Gangliosides Ab1 and Ab2 antibodies II. Light versus heavy chain: an idiotype-anti-idiotype case study. Mol. Immunol. 44 (2007) 1015-1028
26. Lou Q., Kelleher Jr. R.J., Sette A., Loyall J., Southwood S., Bankert R.B., and Bernstein S.H. Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells. Blood 104 (2004) 752-759
27. Malykh Y.N., Schauer R., and Shaw L. N-Glycolylneuraminic acid in human tumours. Biochimie 83 (2001) 623-634
28. Marquina G., Waki H., Fernández L.E., Kon K., Carr A., Valiente O., Pérez R., and Ando S. Gangliosides expressed in human breast cancer. Cancer Res. 56 (1996) 5165-5171
29. Matsushita T., Elliger S., Elliger C., Podsakoff G., Villarreal L., Kurtzman G.J., Iwaki Y., and Colosi P. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5 (1998) 938-945
30. Pérez A., Lombardero J., Mateo C., Mustelier G., Alfonso M., Vázquez A.M., and Pérez R. Immunogenetic analysis of variable regions encoding Ab1 and -type Ab2 antibodies from the NeuGc-containing ganglioside family. Hybridoma 20 (2001) 211-221
31. Pérez A., Mier E.S., Vispo N.S., Vázquez A.M., and Pérez R. A monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells. Mol. Immunol. 39 (2002) 103-112
32. Reitan S.K., and Hannestad K. A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG. Eur. J. Immunol. 25 (1995) 1601-1608
33. Reitan S.K., and Hannestad K. The primary IgM repertoire: a source of potent idiotype immunogens. Eur. J. Immunol. 31 (2001) 2143-2153
34. Reitan S.K., and Hannestad K. Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7588-7593
35. Rodríguez M., Roque-Navarro L., López-Requena A., Moreno E., Mateo de Acosta C., Pérez R., and Vázquez A.M. Insights into the immunogenetic basis of two ganglioside-associated idiotypic networks. Immunobiology 212 (2007) 57-70
36. Varki A. Diversity in the sialic acids. Glycobiology 2 (1992) 25-40
37. Vázquez A.M., Alfonso M., Lanne B., Karlsson K.-A., Carr A., Barroso O., Fernández L.E., Rengifo E., Lanio M.E., Alvarez C., Zeuthen J., and Pérez R. Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 14 (1995) 551-556
38. Vázquez A.M., Pérez A., Hernández A.M., Macías A., Alfonso M., Bombino G., and Pérez R. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 17 (1998) 527-534
39. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
40. Watarai S., Kushi Y., Shigeto R., Misawa N., Eishi Y., Handa S., and Yasuda T. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides N-glycolylneuraminic acid-containing gangliosides. J. Biochem. (Tokyo) 117 (1995) 1062-1069
41. Wysocki L.J., Zhang X., Smith D.S., Snyder C.M., and Bonorino C. Somatic origin of T-cell epitopes within antibody variable regions: significance to monoclonal therapy and genesis of systemic autoimmune disease. Immunol. Rev. 162 (1998) 233-246
42. Zaghouani H., Krystal M., Kuzu H., Moran T., Shah H., Kuzu Y., Schulman J., and Bona C. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells. J. Immunol. 148 (1992) 3604-3609
43. Zaiss A.K., Liu Q., Bowen G.P., Wong N.C., Bartlett J.S., and Muruve D.A. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J. Virol. 76 (2002) 4580-4590
44. Zaiss A.K., and Muruve D.A. Immune responses to adeno-associated virus vectors. Curr. Gene Ther. 5 (2005) 323-331
45. Zhang X., Smith D.S., Guth A., and Wysocki L.J. A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 166 (2001) 1562-1571